Figure 1From: Renoprotective capacities of non-erythropoietic EPO derivative, ARA290, following renal ischemia/reperfusion injuryThe effect of ARA290 on markers of renal function. Early ARA290 treatment significantly reduced serum creatinine levels at three days post-reperfusion. Late- and repetitive ARA290 treatment tended to reduce serum creatinine levels to a lesser extent (A, p < 0.05). The treatment effect of ARA290 on serum urea levels showed the same tendency as the effect on serum creatinine levels (B).Back to article page